R&D News | pharmaphorum

News

New auction for 23andMe sought with $305m bid from ex-CEO

A new auction for bankrupt genetic testing company 23andMe looks likely after former CEO Anne Wojcicki offered to outbid Regeneron.

News

Has mRNA delivered a breakthrough in quest for HIV cure?

A new way to deliver mRNA to T cells could allow HIV that is hiding away to be exposed and targeted with antiretroviral therapies, say scientists.

News

EU: Trials should include pregnant subjects where possible

With new guidance, the EMA is seeking to ramp up the inclusion of pregnant and breastfeeding women in clinical trials.

News

Neuralink raises $650m to widen use of brain implants

Brain-computer interface firm Neuralink has completed a $650m financing that it says will help to "bring our technology to more people."

News

Ascletis says oral acne drug shows "exceptional efficacy"

Phase 3 results for Ascletis' novel acne candidate have set up filings in China and bode well for a similar drug being developed by Sagimet in the US.

News

MSD rumoured to be eyeing $3bn+ MoonLake takeover

Faced with the looming loss of patent protection for Keytruda, MSD is reported to be interested in buying Swiss immunology player MoonLake.

New auction for 23andMe sought with $305m bid from ex-CEO

Has mRNA delivered a breakthrough in quest for HIV cure?

EU: Trials should include pregnant subjects where possible

Neuralink raises $650m to widen use of brain implants

Ascletis says oral acne drug shows "exceptional efficacy"

MSD rumoured to be eyeing $3bn+ MoonLake takeover

Merck rare tumour drug Ezmekly backed for NHS use

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks